Clinical Trial Update: Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of daily topical dutasteride in men with androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• dutasteride (topical) (dutasteride)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Male Androgenetic Alopecia | Phase 2 | Status: COMPLETED